Skip to content

In Europe, Sun Pharma has always had a focus on developing and offering hospital products in oncology and other areas.
Since the acquisition of Ranbaxy in 2015, a portfolio of retail products was added.
For the European hospital market, Sun aims to develop iv products that are convenient to use, such as Ready-to-Administer products in bags and syringes.
The first result of this initiative is launched in 2016.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.